COMBINING MR BLOCKERS WITH SGLT2 INHIBITORS PREVENT MR BLOCKER-INDUCED HYPERKALEMIA VIA REGULATION OF TWIK1 AND TASK2 IN THE PROXIMAL TUBULE

WCN23-0136
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
 
 
 
 
COMBINING MR BLOCKERS WITH SGLT2 INHIBITORS PREVENT MR BLOCKER-INDUCED HYPERKALEMIA VIA REGULATION OF TWIK1 AND TASK2 IN THE PROXIMAL TUBULE
Nakamura, M.(1)*;Satoh, N.(1);Mizuno, T.(1);Takagi, M.(1);Horita, S.(1);Nangaku, M.(1);
ie: Azwin Z.1, Siti Y.1, John D.2
(1)The University Of Tokyo Hospital, Division Of Nephrology And Endocrinology, Tokyo, Japan;
https://storage.unitedwebnetwork.com/files/1041/0bc5673a9ebaad26f94fcfb7b94e9fbb.pdf
 
if any